Neuregulin 1/ErbB4 signaling contributes to the anti-epileptic effects of the ketogenic diet.
Neuregulin 1/ErbB4 signaling contributes to the anti-epileptic effects of the ketogenic diet.
复制标题
Neuregulin 1/ErbB4 信号传导有助于生酮饮食的抗癫痫作用
DOI:
10.1186/s13578-021-00536-1
复制
发表时间:
2021-02-03
影响因子:
7.5
通讯作者:
Sun XD
中科院分区:
文献类型:
--
作者:
Wang J;Huang J;Li YQ;Yao S;Wu CH;Wang Y;Gao F;Xu MD;Huang GB;Zhao CQ;Wu JH;Zhang YL;Jiao R;Deng ZH;Jie W;Li HB;Xuan A;Sun XD
The ketogenic diet (KD) has been recognized as a potentially effective therapy to treat neuropsychiatric diseases, including epilepsy. Previous studies have indicated that KD treatment elevates γ-Amino butyric acid (GABA) levels in both human and murine brains, which presumably contributes to the KD’s anti-seizure effects. However, this has not been systematically investigated at the synaptic level, and the underlying molecular mechanisms remain to be elucidated. Kainic acid (KA)-induced acute and chronic seizure models were utilized to examine the effects of KD treatment on seizure threshold and epileptogenesis. Synaptic activities in the hippocampus were recorded with the technique of electrophysiology. The effects of the KD on Neuregulin 1 (Nrg1) expression were assessed via RNA sequencing, real-time PCR and Western blotting. The obligatory role of Nrg1 in KD’s effects on seizures was evaluated through disruption of Nrg1 signaling in mice by genetically deleting its receptor-ErbB4. We found that KD treatment suppressed seizures in both acute and chronic seizure models and enhanced presynaptic GABA release probability in the hippocampus. By screening molecular targets linked to GABAergic activity with transcriptome analysis, we identified that KD treatment dramatically increased the Nrg1 gene expression in the hippocampus. Disruption of Nrg1 signaling by genetically deleting its receptor-ErbB4 abolished KD’s effects on GABAergic activity and seizures. Our findings suggest a critical role of Nrg1/ErbB4 signaling in mediating KD’s effects on GABAergic activity and seizures, shedding light on developing new therapeutic interventions to seizure control.
登录
查看更多内容
DOI:
10.1126/science.1227166
发表时间:
2013-01-11
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Shimazu T;Hirschey MD;Newman J;He W;Shirakawa K;Le Moan N;Grueter CA;Lim H;Saunders LR;Stevens RD;Newgard CB;Farese RV Jr;de Cabo R;Ulrich S;Akassoglou K;Verdin E
通讯作者:
Verdin E
影响因子:
5.3
作者:
Bean, Jonathan C.;Lin, Thiri W.;Mei, Lin
通讯作者:
Mei, Lin
DOI:
10.1073/pnas.1010669107
发表时间:
2010-12-14
影响因子:
11.1
作者:
Chen, Yong-Jun;Zhang, Meng;Gao, Tian-Ming
通讯作者:
Gao, Tian-Ming
影响因子:
21.1
作者:
Brodie MJ;Besag F;Ettinger AB;Mula M;Gobbi G;Comai S;Aldenkamp AP;Steinhoff BJ
通讯作者:
Steinhoff BJ
影响因子:
16.2
作者:
Juge, Narinobu;Gray, John A.;Omote, Hiroshi;Miyaji, Takaaki;Inoue, Tsuyoshi;Hara, Chiaki;Uneyama, Hisayuki;Edwards, Robert H.;Nicoll, Roger A.;Moriyama, Yoshinori
通讯作者:
Moriyama, Yoshinori